MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Potential BlockBuster Technology and/or Business Model
Pioneers: Triple Helix: New Business Models_Open Innovation, Virtual Organizations, Royalty Aggregators, Etc.
RICS (Regional Innovation Clusters) - Medical, Life Sciences & Emerging Technology Hotspots
*Industry: Research Triangle, North Carolina
*Bioscience Regional Clusters & HotSpots
*Industry: Northern California & Silicon Valley
CV Ingenuity
Parents
*Architects: Surgical & Diagnostic Technology _ Vascular, PAD (Peripheral Arterial Disease & CLI (Critical Limb Ischemia)
*Industry: Northern California & Silicon Valley
Companies: Acquired_(M&A)
Finance & Acquisitions: Covidien
Children
2012: Covidien to acquire Calif. angioplasty co., CV Ingenuity (2012)
CVI is advancing a new approach to treating peripheral artery disease, which causes restricted blood flow in the arms and legs, increasing patient's risk of having a stroke, heart attacks and needing to have a limb amputated.
CVI's system appears to be different, bring the benefit during procedures of delivering drugs intended to prevent blood vessels from narrowing.
In certain cases of PAD, patients get angioplasties that involve balloon catheters to open blood vessels and improve blood flow.
NEA leads $16M round for drug-eluting balloon firm (2011)
New Enterprise Associates led the second-round financing, which included funding from return investors BioStar Ventures, Synergy Ventures and Western Technology.
Palo Alto, California
Procedures done with system, unlike some angioplasties, do not involve implanting stents to prop open diseased arteries. Read more: NEA leads $16M round for drug-eluting balloon firm - FierceMedicalDevices http://www.fiercemedicaldevices.com/story/nea-lea